Results 121 to 130 of about 519,396 (228)

Mortality and Serious Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists: A Pharmacovigilance Study Using the FDA Adverse Event Reporting System [PDF]

Mehul Bhattacharyya, Larry E. Miller, Anna L. Miller, Ruemon Bhattacharyya   +3 more
openalex   +1 more source

Pancreatitis Associated With Teduglutide: A Disproportionality Analysis via the Food and Drug Administration Adverse Event Reporting System (FAERS) Database [PDF]

Joyce H Gu, Zachary Sheingold, Mark Samarneh   +2 more
openalex   +1 more source

A systemic methodology for risk management in healthcare sector [PDF]

, 2011
Anna Corinna Cagliano, Apkon, Armitage, Barach, Bartlett, Baysari, Baysari, Bridges, Brown, Burgmeier, Carlo Rafele, Cohen, Cosby, Damelio, Davis, Embrey, Embrey, Garthwaite, Graham, Gray, Harms-Ringdahl, Harvard Business School, Hillson, Hillson, Hollnagel, Hollnagel, Janssen, Johansson, Körvers, Leape, Liker, Liker, Linch, Lucas, Lyons, Lyons, McDonald, McNally, Norman, Ohno, Ookalkar, O’Hagan, Paz Barroso, Project Management Institute, Project Management Institute, Reason, Reason, Ross Baker, Roth, Sabrina Grimaldi, Saizy-Callaert, Sale, Stalhandske, Thomas, Tonneau, Vincent, Vincent, Vincent, Vissers, Wiegmann, Wieman, Wilson, Zidel   +62 more
core   +1 more source

Pharmacovigilance study on neurological adverse reactions of proteasome inhibitors in the FDA adverse event reporting system. [PDF]

Front Pharmacol
Li S, Ling T, Liu Y, Li J.
europepmc   +1 more source

Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn’s disease medications and hepatosplenic T-cell lymphoma [PDF]

, 2013
Saranya Selvaraj, Elizabeth Chairez, Lisa M Wilson, Mark Lazarev, Eric B Bass, Susan Hutfless   +5 more
openalex   +1 more source

Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline [PDF]

Clinical Gastroenterology and Hepatology, 2018
Victor Chedid, Priya Vijayvargiya, Michael Camilleri   +2 more
openaire   +2 more sources

Adverse events following Synflorix vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 2010-2024. [PDF]

PLoS One
Cui L, Tong N, Hou S, Yu C.
europepmc   +1 more source

Investigating Drug-Induced Thyroid Dysfunction Adverse Events Associated With Non-Selective RET Multi-Kinase Inhibitors: A Pharmacovigilance Analysis Utilizing FDA Adverse Event Reporting System Data

Zihan Meng, Liying Song, Shuang Wang, Guosheng Duan   +3 more
openalex   +2 more sources

Analysis of adverse drug reactions of Denosumab (Prolia) in osteoporosis based on FDA adverse event reporting system (FAERS) [PDF]

Ruibo Li, Xingyue Yuan, Xi Chen, Yili Ou, Jin Chen   +4 more
openalex   +1 more source

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for bimekizumab. [PDF]

Front Pharmacol
Lin Z, Yu X, Yang M, Xu J, Zhong J.
europepmc   +1 more source